Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antigenic Targets Compared for Melioidosis Serodiagnosis

By LabMedica International staff writers
Posted on 13 Apr 2017
Melioidosis, caused by Burkholderia pseudomallei, is a life-threatening infection endemic in tropical countries and definitive diagnosis of the disease relies upon bacterial culture, which requires suitable laboratory facilities and reliable antibody testing.

A rapid point-of-care serological test with high sensitivity and specificity would be ideal for use in resource-poor areas where melioidosis is endemic. More...
To develop such assays, identification of good serologic markers is critical. It is also important to evaluate whether an assay can differentiate between acute melioidosis and previous infection or exposure.

Scientists at Mahidol University and their colleagues collected two sets of anonymous human serum samples were used to evaluate the enzyme-linked immunosorbent assays (ELISAs). The first set included 141 on-admission sera from culture-confirmed B. pseudomallei infected patients who were admitted to hospital, 188 serum samples obtained from healthy donors from the same area in northeast Thailand and 90 serum samples obtained from healthy USA donors.

To evaluate the diagnostic potential of hemolysin co-regulated protein (Hcp1) and O-polysaccharide (OPS) antigens for determination of antibody titers in different groups of melioidosis patients, another set of independent serum samples was used. This set included serum samples obtained from 200 patients with culture-confirmed melioidosis collected a median of 5 days, and 113 at 12 weeks and 110 at 52 weeks post-recovery. The patients were recruited in a longitudinal clinical and immunological study during September 2012-October 2015.

The team detected high levels of antibodies to Hcp1 and OPS in serum from melioidosis patients upon admission and showed that anti-Hcp1 levels declined post-recovery. When serum samples from endemic areas were tested, the performance of the Hcp1-ELISA and combined Hcp1/OPS-ELISA were higher than the OPS-ELISA. When serum from non-endemic areas was tested, the combined Hcp1/OPS-ELISA gave the highest performance. Both the OPS- and Hcp1-based ELISAs were useful for detection of antibodies in various groups of patients including diabetics.

The authors concluded that that Hcp1 and OPS are useful targets for serodiagnosis of melioidosis in various groups of patients. Overall, the Hcp1-ELISA provided better diagnostic assay values than the OPS-ELISA. When used in non-endemic areas, a combined Hcp1/OPS showed increased sensitivity compared to the ELISAs for Hcp1 or OPS alone. Their results support accelerated development of Hcp1-based assays for a much needed point of- care test for the diagnosis of acute melioidosis. The study was published on March 30, 2017, in the journal Public Library of Science Neglected Tropical Diseases.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.